Histopathological and biochemical changes of morphine sulphate administration on the cerebellum of albino rats

Tissue and Cell

Volumn 42, Issue 3, 2010, Pages 165-175

  Bekheet, S H ^a   Saker, S A ^b   Abdel Kader, A M ^a   Younis, A E A ^a  

^a ASWAN UNIVERSITY   (Egypt)

^b MENOUFIA UNIVERSITY   (Egypt)

Author keywords

Biochemical; Cerebellum; Histology; Morphine sulphate; Neurotransmitter levels; Rat

Indexed keywords

BRAIN PROTEIN; CARBOHYDRATE; DOPAMINE; MORPHINE SULFATE; MS CONTINUS; NORADRENALIN; SEROTONIN; SODIUM CHLORIDE; UNCLASSIFIED DRUG; MORPHINE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BIOCHEMISTRY; BRAIN REGION; CELL COUNT; CELL DEATH; CELL MEMBRANE; CELL SHAPE; CELL SIZE; CELL VACUOLE; CEREBELLUM; CONTROLLED STUDY; ELECTRON MICROSCOPY; ENDOPLASMIC RETICULUM; GRANULAR CELL; HISTOCHEMISTRY; HISTOPATHOLOGY; HYPOTHALAMUS; MALE; MEMBRANE DAMAGE; MICROSCOPY; MITOCHONDRIAL MEMBRANE; NERVE CELL DEGENERATION; NERVE CELL NECROSIS; NEUROTOXICITY; NONHUMAN; NUCLEAR SHAPE; PROTEIN DEPLETION; PURKINJE CELL; QUANTITATIVE ANALYSIS; RAT; STRIATE CORTEX; SYNAPSE; THALAMUS; TREATMENT DURATION; ALBINISM; ANIMAL; BODY WEIGHT; DRUG EFFECTS; IMMUNOHISTOCHEMISTRY; METABOLISM; PATHOLOGY; TOXICITY; ULTRASTRUCTURE;

RATTUS;

ALBINISM; ANIMALS; BODY WEIGHT; CELL DEATH; CEREBELLUM; DOPAMINE; ENDOPLASMIC RETICULUM; IMMUNOHISTOCHEMISTRY; MORPHINE; NOREPINEPHRINE; PURKINJE CELLS; RATS; SEROTONIN;

EID: 77955267661     PISSN: 00408166     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.tice.2010.03.005     Document Type: Article

References (68)

1. Abdel-Moneim L.A. Morphine-induced histological and histochemical changes in kidney and adrenal gland of neonatal and young rats. J. Egypt Soc. Zool. 2001, 36(C):207-227.
2. Abdel-Reheem K., El-Mossallamy N., El-Feki M., EL-Gabry M., El-Yamany N. Carbohydrate metabolism in response to administration of heroin at fixed doses. Proc. Zool. Soc. A. R. Egypt. 1991, 22:149-165.
3. Ashry M.A., Wahba S.R., Abdel-Mageid S.A. Histological and histochemical change in response to the administration and withdrawal of codeine on liver of rat. Egypt. J. Histol. 1990, 13(1):3-12.
4. Atta F.A.M. Depressant of morphine on cellular composition of lymphoid tissues and cerebellum in rats. J. Egypt Ger. Soc. Zool. 2002, 39(C):411-438.
5. Bayomy M.F., El-Mossallamy N., El-Dieb S., El-Deen A.N. Changes in amino acids and proteins in response to chronic d-amphetamine administration and drug withdrawal in rat brain. J. Egypt. Ger. Soc. Zool. 1992, 8(A):251-264.
6. Brands A., Munzel P.A., Bock K.W. In situ hybridization studies of UDPglucuronosyltransferase UGT1A6 expression in rat testis and brain. Biochem. Pharmacol. 2000, 59:1441-1444.
7. Cheng N., Quimby F.W., Lei X.G. Impacts of glutathione peroxidase-1 knockout on the protection by injected selenium against the pro-oxidant-induced liver aponecrosis and signaling in selenium deficient mice. Free Radic. Biol. Med. 2003, 34(7):918-927.
8. Ciarolone A.E. Further modification of a fluorometric method for analyzing brain amines. Microchem. J. 1978, 23:9-12.
9. Collet B.J. Chronic opioid therapy for non-cancer pain. Br. J. Anaesth. 2001, 87:133-143.
10. Demeri O., Celik I.M., Sur E., Ozkan Y., Aydin M.F., Salbacak A. Histological and morphometric studies of the cerebellar cortex and nucleolus organizer region (Ag-Nors) in Purkinje neurons of chronic morphine treated rats. Proceedings of the XVII Intern. Symposium on Morphological Science 2002.
11. Dmbska M., Gajkowska B. Hypoxic damage of the cerebellum in 7-day-old rats Ultrastructural and histochemical study. Acta Neurobiol. Exp. 2002, 62:45-49.
12. El-Banhawy M.A., Al-Zahaby A.S., Sand S.M., Hashem A. Effect of the anaesthetic drug ketamine hydrochloride on the Golgi apparatus and mitochondria of rat nerve cells. Acta Neurobiol. Exp. 1993, 62:31-69.
13. El-Sherif G., Gabri S., Zahran W.M., Abdel-Hamid T.F. Histological, histochemical studies and ATP-ase localization in the rat liver after morphine sulphate induction. J. Egypt. Ger. Soc. Zool. 2002, 39(C):175-187.
14. Farber N.B., Onley J.W. Drugs of abuse that cause developing neurons to commit suicide. Dev. Brain Res. 2003, 147:37-45.
15. Figlewicz D.P. Endocrine regulation of neurotransmitter transporters. Epilepsy Res. 1999, 37:203-210.
16. Fleckell P.A. The relief of pain in laboratory animals. Lab. Anim. 1984, 18:147-160.
17. Foster G.L., Falcon A.J., Miller A.D., Heruc G., Blaha C.D. Behavioral and neurochemical responses evoked by morphine and d- amphetamine: comparisons of laterodorsal and pednulepontine tegmental nucleus lesioned rats. Eur. Neurosci. 2001, 18:1-12.
18. Gajkowska B., Motyl T., Olszewska-Bdarczuk H., Gniadecki R., Koronkiewicz M. Structural association of Bax with nuclear matrix and cytomatrix revealed by embedment-free immunogold electron microscopy. Cell Biol. Monogr. 2000, 24:649-656.
19. 28k immunoreactivity in a subset of cerebellar Purkinje neurons of rat brain. Brain Res. 1996, 734:123-134.
20. Goumon Y., Muller A., Glattard E., Marban C., Gasnier C. Identification of morphine-6-glucuronide in chromaffin cell secretory granules. J. Biol. Chem. 2006, 281:8082-8089.
21. Guarna M., Ghelardini G., Galeotti N., Stefano G.B., Bianchi E. Neurotransmitter role of endogenous morphine in CNS. Med. Sci. Monit. 2005, 11(6):190-193.
22. Hauser K.F. Morphine regulates DNA synthesis in rat cerebellar neuroblasts in vitro. J. Dev. Brain Res. 1992, 70:291-297.
23. Hauser K.F., Gurwell J.A., Turbek C.S. Morphine inhibits Purkinje cell survival and dendritic differentiation in organotypic cultures of the mouse cerebellum. Exp. Neurol. 1994, 130:95-105.
24. 2+ homeostasis and induce carbonyl oxyradical production in mouse astrocytes in vitro: transient increases and adaptation to sustained exposure. Exp. Neurol. 1998, 151:70-76.
25. Hauser K.F., Houdi A.A., Turbeck C.S., Elde R.P., Maxson W. Opioids intrinsically inhibit the genesis of mouse cerebellar granule neuron precursors in vitro: differential impact of μ and δ receptor activation on proliferation and neurite elongation. Eur. J. Neurosci. 2000, 12:1281-1293.
26. Heurtaux T., Benani A., Moulin D., Muller N., Netter P., et al. Induction of UGT1A6 isoform by inflammatory conditions in rat astrocytes. Neuropharmacology 2006, 50:317-328.
27. Hiroko S. Inhibitory and stimulatory effects of morphine on locomotor activity in mice: biochemical and behavioral studies. Pharmacol. Biochem. Behav. 1990, 35(1):231-235.
28. Jacob, J.T., 2007. Effect of the cardiac glycoside digoxin, on neuronal viability, serotonin production and brain development in the embryo. M.Sc. Thesis in anatomy with specialization in cell biology. School of Medicin, Faculty of Health Science, University of Pretoria, South Africa.
29. Powell K.R., Holtzman S.G. Drug Alcohol Depend. 2001, 62(1):83-90.
30. Kinney H.C., White W.F. Opioid receptors localize to the external granular cell layer of the developing human cerebellum. Neuroscience 1991, 45:13-21.
31. Li K.W., Jimenez C.R., van der Schors R.C., Hornshaw M.P., Schoffelmeer A.N., Smit A.B. Intermittent administration of morphine alters protein expression in rat nucleus accumbens. Proteomics 2006, 6:2003-2008.
32. Mackenzie P.I., Walter Bock K., Burchell B., Guillemette C., Ikushiro S., et al. Nomenclature update for the mammalian UDP glycosyltransferase (UGT) gene superfamily. Pharmacogenet. Genom. 2005, 15:677-685.
33. Matthew R., Ray T. Anaethesia and liver. Physiology 1999, 10(5):1-4.
34. Minitab release 12 Statistical Software User's Guide 1998, State College, PA, USA.
35. Morón J.A., Abul-Husn N.S., Rozenfeld R., Dolios G., Wang R., Devi L.A. Morphine administration alters the profile of hippocampal postsynaptic densityassociated proteins: a proteomics study focusing on endocytic proteins. Mol. Cell Proteomics 2007, 6:29-42.
36. Motyl T., Gajkowska B., Poszaj T., Warêski P., Skierski J., Zimowska W. Expression and subcellular redistribution of Bax during TGF B1-induced programmed cell death of HC11 mouse mammary epithelial cells. Cell. Mol. Biol. 2000, 46:175-185.
37. Muller A., Elise Glattard E., Taleb O., Kemmel V., Laux A., Miehe M., Delalande F., Roussel G., Dorsselaer A. Endogenous morphine in SH-SY5Y cells and the mouse cerebellum. PLoS ONE 2008, 3(2.):1-13.
38. Nagamastu K., Ohno Y., Ikebuchi H., Takahashi A., Terao T., Takanaka A. Morphine metabolism in isolated rat hepatocytes and its implications for hepatotoxicity. Biochem. Pharmacol. 1986, 35(20):3543-3548.
39. Nagano E., Yamada H., Oguri K. Characteristic glucuronidation pattern of physiologic concentration of morphine in rat brain. Life Sci. 2000, 67:2453-2464.
40. Neasta J., Uttenweiler-Joseph S., Chaoui K., Monsarrat B., Meunier J.C., Moulédous L. Effect of long-term exposure of SH-SY5Y cells to morphine: a whole cell proteomic analysis. Proteome Sci. 2006, 4:23.
41. Nestler E.J., Aghajanian G.K. Molecular and cellular basis of addiction. Science 1997, 278:58-63.
42. Taraschenko O.D., Rubbinaccio H.Y., Shulan J.M., Glick S.D., Maisonneuve I.M. Morphine-induced changes in acetylcholine release in the interpeduncular nucleus and relationship to changes in motor behavior in rats. Neuropharmacology 2007, 53(1):18-26.
43. Paul S. Morphine tolerance and sensitization in the Hamster. Pharmacol. Biochem. Behav. 1985, 22(1.):157-158.
44. Payabvash S., Beheshtian A., Salmasi A.H., Kiumehr S., Ghahremani M.H., Tavangar S.M., Sabzevari O., Dehpour A.R. Chronic morphine treatment induces oxidant and apoptotic damage in the mice liver. Life Sci. 2006, 79(10):972-980.
45. Pretorius E., Bornman M.S. Calcium-mediated aponecrosis plays a central role in the pathogenesis of estrogenic chemical-induced neurotoxicity. Med. Hypotheses 2005, 65:893-904.
46. Prokai L., Zharikova A.D., Stevens S.M. Effect of chronic morphine exposure on the synaptic plasma-membrane subproteome of rats: a quantitative protein profiling study based on isotope-coded affinity tags and liquid chromatography/mass spectrometry. J. Mass Spectrom. 2005, 40:169-175.
47. Quang-Cantagrel N.D., Wallace M.S., Magnuson S.K. Opioid substitution to improve the effectiveness of chronic noncancer pain control a chart review. Anesth. Analg. 2000, 90:933-937.
48. Richard D.H., Mary J.M., Richard A.H., Pamela C.C. Lippincott's Illustrated Reviews. Pharmacology 2006, Lippincott Williams & Wilkins Publishers, p. 162. 3rd edition.
49. Said K.M., Abou-Deya S.H. Long-term caffeine administration to mice could be hepatotoxic. J. Egypt. Ger. Soc. Zool. 1993, 11(A):247-260.
50. Schanberg S.M., Schildkraut J.J., Kopin I. The effect of psychoactive drugs on norepinephrine 3-H metabolism in brain. J. Pharmacol. Exp. Ther. 1967, 157:311-316.
51. Sebenem A., Ismail C., Leyla C., Nurcand D., Gulcin S., Ugur O. Liver and kidney toxicity in chronic use of opioids: an experimental long-term treatment model. J. Biosci. 2005, 30(2):245-252.
52. Snedecor G.W., Chochran W.G. Statistical Methods 1967, Iowa State University Press, Ames, IA, pp. 59-60.
53. Suleman F.G., Abid A., Gradinaru D., Daval J.L., Magdalou J., et al. Identification of the uridine diphosphate glucuronosyltransferase isoform UGT1A6 in rat brain and in primary cultures of neurons and astrocytes. Arch. Biochem. Biophys. 1998, 358:63-67.
54. Tawfek I.A., Gabry M.S., Abdel-Moneim L.A., Ibrahim I.A. Histological and histochemical effects induced by indomethacin on rat cerebellum. J. Egypt. Ger. Soc. Zool. 1997, 23(C):81-107.
55. Taylor B.K., Basbaume A.I. Systemic morphine-induced release of serotonin in the rostroventral medulla is not mimicked by morphine microinjection into the periaqueductal gray. J. Neurochem. 2003, 86:1129-1141.
56. Vinitskaia A.G., Kurbat M.N., Kozlovskiǐ A.V., Lelevich V.V. Chronic morphine intoxication and metabolism of neuroactive amino acids in the rat brain. Biomed. Khim. 2005, 51(3):295-302.
57. Vinitskaia A.G., Lelevich S.V., Lelevich V.V., Kozlovskiǐ A.V., Doroshenko E.M. GABA metabolism and neuroactive amino acids in the rat brain in morphine withdrawal syndrome. Biomed. Khim. 2007, 53(4):427-434.
58. Vogt M. Concentration of sympathin in different parts of central nervous system under normal conditions and after administration of drugs. J. Physiol. (Lond.) 1954, 123:451-457.
59. Welch B.L., Welch A.S. Differential activation by restraint stress of a mechanism of converse brain catecholamines and serotonin in mice differing in excitability. Nature 1968, 218:575-600.
60. Wu D., Kang Y.S., Bickel U., Pardridge W.M. Blood-brain barrier permeability to morphine-6-glucuronide is markedly reduced compared with morphine. Drug Metab. Dispos. 1997, 25:768-771.
61. Yamada H., Ishii K., Ishii Y., Ieiri I., Nishio S., et al. Formation of highly analgesic morphine-6-glucuronide following physiologic concentration of morphine in human brain. J. Toxicol. Sci. 2003, 28:395-401.
62. Yilmaz B., Konar V., Kutlu S., Sandal S., Canpolat S., Gezen M.R., Kelestimur H. Influence of chronic morphine exposure on serum LH, FSH, testosterone levels and body and testicular weights in the developing male rat. Arch. Androl. 1999, 43(3):189-196.
63. Zagon I.S., McLaughlin P.J. Identification of opioid peptides regulating proliferation of neurons and glia in the developing nervous system. Brain Res. 1991, 542:318-323.
64. Zahran F.M. Effect of heroin administration on certain biochemical aspects in adult rabbits. Egypt. J. Med. Sci. 1994, 15(1):69-78.
65. Zelcer N., van de Wetering K., Hillebrand M., Sarton E., Kuil A., et al. Mice lacking multidrug resistance protein 3 show altered morphine pharmacokinetics and morphine-6-glucuronide antinociception. Proc. Natl. Acad. Sci. U.S.A. 2005, 102:7274-7279.
66. Zhu W., Mantione K.J., Kream R.M., Cadet P., Stefano G.B. Cholinergic regulation of morphine release from human white blood cells: evidence for a novel nicotinic receptor via pharmacological and microarray analysis. Int. J. Immunopathol. Pharmacol. 2007, 20:229-237.
67. Zhu W., Mantione K., Kream R.M., Stefano G.B. Alcohol-, nicotine-, and cocaine-evoked release of morphine from human white blood cells: substances of abuse actions converge on endogenous morphine release. Med. Sci. Monit. 2006, 12:BR350-BR354.
68. Zimmerman G., Soreq H. Termination and beyond: acetylcholinesterase as a modulator of synaptic transmission. Cell Tissue Res. 2006, 326:655-669.